Transdel Pharmaceuticals makes appointment
This article was originally published in Scrip
Transdel Pharmaceuticals, a US speciality pharmaceutical company developing topically administered products using its proprietary transdermal delivery platform, has named Dr Joachim Schupp chief medical officer. Most recently, Dr Schupp has worked as an executive consultant for pharmaceutical and biotechnology companies. He also served vice-president of medical affairs at Adventrx Pharmaceuticals from 2006-08 and vice-president of clinical data services at ProSanos from 2004-06.